Click here to return to the LMHS Home Page

 

Services

Hospital Facilities

Cancer Services

Corporate Health Services

Emergency Services

Heart Services

Kidney Services

Mental Health Services

Neuroscience Services

Nursing Home

Orthopedic and Spine Services

Outpatient Services

Patient Services

Pediatric Services

Physician Locator Services

Primary Care Services

Pulmonary Services

Rehabilitation Services

Sleep Services

Surgical Services

Urgent Care Services

Volunteer Services

Weight Loss Services

Wellness Services

Women's Health Services

Wound Care Services

Sertoli-Leydig cell tumor

Definition

Sertoli-Leydig cell tumor is a rare cancer of the ovaries. The cancer cells produce and release a male sex hormone.

This article focuses on Sertoli-Leydig cell tumors in women. For information on Sertoli-Leydig cell tumors in men, see the article on testicular cancer.

Alternative Names

Arrhenoblastoma

Symptoms

The Sertoli cells are normally located in the male reproductive glands (the testes). They feed sperm cells. The Leydig cells, also located in the testes, release a male sex hormone called testosterone.

These cells are also found in a woman's ovaries and may lead to cancer. A Sertoli-Leydig cell tumor is a cancer that starts in the female ovaries, usually in younger women. The cancer cells release a male sex hormone that may cause the woman to develop facial hair, a deep voice, and other male characteristics.

In men, some cancers of the testes can start in the Sertoli and Leydig cells. These are considered types of testicular cancer. For information on Sertoli-Leydig cell tumors in men, see the article on testicular cancer.

References

Einhorn LH. Testicular cancer. In Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 206.

Markham M. Gynecologic cancers. In Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 205.


Review Date: 6/5/2012
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
 

home  |  about us  |  services  |  locations  | employmentpatient billing  |  press room  |  events  |  foundation

HIPAA | privacy policy | did you find it? | medical staff | send a link | get well card